Q9ELS8 (Q9ELS8_9HEPC) Unreviewed, UniProtKB/TrEMBL
Last modified
January 25, 2012.
Version 86.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry infoCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry infoCustomize orderNames and origin
| Protein names | Recommended name: Genome polyprotein RuleBase RU003358 |
| Organism | Hepatitis C virus subtype 1a EMBL AAG02099.1 |
| Taxonomic identifier | 31646 [NCBI] |
| Taxonomic lineage | Viruses › ssRNA positive-strand viruses, no DNA stage › Flaviviridae › Hepacivirus |
Protein attributes
| Sequence length | 3011 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Catalytic activity | ATP + H2O = ADP + phosphate. SAAS SAAS007094 NTP + H2O = NDP + phosphate. SAAS SAAS007094 Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1). SAAS SAAS007094 |
| Sequence similarities | Contains 1 RdRp catalytic domain. SAAS SAAS007094 |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Sites | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Metal binding | 1123 | 1 | Zinc PDB 2FM2 PDB 2O8M PDB 2OBO PDB 2OBQ PDB 2OC0 PDB 2OC1 PDB 2OC7 PDB 2OC8 PDB 3KNX PDB 3LON PDB 3LOX | ||||||
| Metal binding | 1124 | 1 | Zinc; via carbonyl oxygen PDB 2OC7 | ||||||
| Metal binding | 1125 | 1 | Zinc PDB 2FM2 PDB 2O8M PDB 2OBO PDB 2OBQ PDB 2OC0 PDB 2OC1 PDB 2OC7 PDB 2OC8 PDB 3KNX PDB 3LON PDB 3LOX | ||||||
| Metal binding | 1171 | 1 | Zinc PDB 2FM2 PDB 2O8M PDB 2OBO PDB 2OBQ PDB 2OC0 PDB 2OC1 PDB 2OC7 PDB 2OC8 PDB 3KNX PDB 3LON PDB 3LOX | ||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Hepatitis C Virus." Desai S.M., Devare S., Yamaguchi J. Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE. Strain: Colonel EMBL AAG02099.1. |
| [2] | "Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus." Ching W.M., Wychowski C., Beach M.J., Wang H., Davies C.L., Carl M., Bradley D.W., Alter H.J., Feinstone S.M., Shih J.W. Proc. Natl. Acad. Sci. U.S.A. 89:3190-3194(1992) [PubMed: 1373489] [Abstract] Cited for: NUCLEOTIDE SEQUENCE. |
| [3] | "Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity." Simmonds P., McOmish F., Yap P.L., Chan S.W., Lin C.K., Dusheiko G., Saeed A.A., Holmes E.C. J. Gen. Virol. 74:661-668(1993) [PubMed: 8385694] [Abstract] Cited for: NUCLEOTIDE SEQUENCE. |
| [4] | "Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutations." Yi M., Tong X., Skelton A., Chase R., Chen T., Prongay A., Bogen S.L., Saksena A.K., Njoroge F.G., Veselenak R.L., Pyles R.B., Bourne N., Malcolm B.A., Lemon S.M. J. Biol. Chem. 281:8205-8215(2006) [PubMed: 16352601] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 1027-1207 AND 1680-1696 IN COMPLEX WITH ZINC. |
| [5] | "Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization." Prongay A.J., Guo Z., Yao N., Pichardo J., Fischmann T., Strickland C., Myers J., Weber P.C., Beyer B.M., Ingram R., Hong Z., Prosise W.W., Ramanathan L., Taremi S.S., Yarosh-Tomaine T., Zhang R., Senior M., Yang R.S. Madison V.J. Med. Chem. 50:2310-2318(2007) [PubMed: 17444623] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 1027-1207 IN COMPLEX WITH ZINC. |
| [6] | "Discovery and structure-activity relationship of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease." Venkatraman S., Velazquez F., Wu W., Blackman M., Chen K.X., Bogen S., Nair L., Tong X., Chase R., Hart A., Agrawal S., Pichardo J., Prongay A., Cheng K.C., Girijavallabhan V., Piwinski J., Shih N.Y., Njoroge F.G. J. Med. Chem. 52:336-346(2009) [PubMed: 19102654] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 1027-1207 AND 1680-1696 IN COMPLEX WITH ZINC. |
| [7] | "Candidate selection and preclinical evaluation culminating in the discovery of Narlaprevir (SCH 900518): A potent, selective and orally efficacious second generation HCV NS3 serine protease inhibitor." Arasappan A., Bennett F., Bogen S.L., Blackman M., Chen K., Hendrata S., Huang Y., Huelgas R.M., Nair L., Padilla A.I., Pan W., Pike R., Pinto P., Ruan S., Sannigrahi M., Velaquez F., Vibulbhan B., Wu W. Njoroge F.G.Submitted (FEB-2010) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 1027-1207 IN COMPLEX WITH ZINC. |
| [8] | "The introduction of P4 substituted 1-methylcyclohexyl groups into Boceprevir: a change in direction in the search for a second generation HCV NS3 protease inhibitor." Bennett F., Huang Y., Hendrata S., Lovey R., Bogen S.L., Pan W., Guo Z., Prongay A., Chen K.X., Arasappan A., Venkatraman S., Velazquez F., Nair L., Sannigrahi M., Tong X., Pichardo J., Cheng K.C., Girijavallabhan V.M., Saksena A.K., Njoroge F.G. Bioorg. Med. Chem. Lett. 20:2617-2621(2010) [PubMed: 20303756] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 1027-1207 IN COMPLEX WITH ZINC. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF290978 Genomic RNA. Translation: AAG02099.1. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PIR | A44150. PQ0804. PS0326. PS0327. PS0328. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | Q9ELS8. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SMR | Q9ELS8. Positions 2-45, 902-1026, 1029-1657, 1973-2003, 2008-2170, 2421-2982. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| euHCVdb | AF290978. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| InterPro | IPR014001. DEAD-like_helicase. IPR011492. DEAD_Flavivir. IPR002521. HCV_core_C. IPR002522. HCV_core_N. IPR002519. HCV_env. IPR002531. HCV_NS1. IPR000745. HCV_NS4a. IPR001490. HCV_NS4b. IPR002868. HCV_NS5a. IPR013193. HCV_NS5a_1B_dom. IPR024350. HCV_NS5a_C. IPR001650. Helicase_C. IPR002518. Pept_C18_HCV_NS2. IPR009003. Pept_cys/ser_Trypsin-like. IPR004109. Peptidase_S29. IPR007094. RNA-dir_pol_PSvirus. IPR002166. RNA_pol_HCV. IPR013192. Znf_HCV_NS5a. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pfam | PF07652. Flavi_DEAD. 1 hit. PF01543. HCV_capsid. 1 hit. PF01542. HCV_core. 1 hit. PF01539. HCV_env. 1 hit. PF01560. HCV_NS1. 1 hit. PF01538. HCV_NS2. 1 hit. PF01006. HCV_NS4a. 1 hit. PF01001. HCV_NS4b. 1 hit. PF01506. HCV_NS5a. 1 hit. PF08300. HCV_NS5a_1a. 1 hit. PF08301. HCV_NS5a_1b. 1 hit. PF12941. HCV_NS5a_C. 1 hit. PF02907. Peptidase_S29. 1 hit. PF00998. RdRP_3. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProDom | PD001388. HCV_env. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SMART | SM00487. DEXDc. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SUPFAM | SSF50494. Pept_Ser_Cys. 1 hit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PROSITE | PS51192. HELICASE_ATP_BIND_1. 1 hit. PS51194. HELICASE_CTER. 1 hit. PS50507. RDRP_SSRNA_POS. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | Q9ELS8_9HEPC | ||||||||
| Accession | Primary (citable) accession number: Q9ELS8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Unreviewed (UniProtKB/TrEMBL) | ||||||||

Clusters with